Plandemic 2.0 will likely see lockdowns and rates reversal followed by mad printing and (eventually) a global monetary reset. Im not even sure miners are the place to be in this decade, as the operational encumbrances may be very difficult to manage. Hard metal, other hard assets, or gold backed ETF may be better. What a shit show these degenerate globalists are creating.
Realistically NST has been priced more for future operation metrics than on current performance. No doubt tax loss selling is playing a part here, but when the future labour and cost input environment are so uncertain, you really have to discount any future earnings accordingly? Even so, today was a bit of a knee jerk, and I'd guess more than a few insto stop losses were triggered snowballing the move
- Forums
- ASX - By Stock
- NST
- So if you bought 5 years ago you are back there
So if you bought 5 years ago you are back there, page-53
-
-
- There are more pages in this discussion • 78 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NST (ASX) to my watchlist
(20min delay)
|
|||||
Last
$15.79 |
Change
-0.010(0.06%) |
Mkt cap ! $18.15B |
Open | High | Low | Value | Volume |
$15.85 | $15.98 | $15.71 | $52.51M | 3.319M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3804 | $15.78 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.79 | 55788 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3804 | 15.780 |
1 | 625 | 15.770 |
4 | 70679 | 15.760 |
4 | 21612 | 15.750 |
2 | 109846 | 15.740 |
Price($) | Vol. | No. |
---|---|---|
15.790 | 55788 | 1 |
15.800 | 46018 | 1 |
15.820 | 13154 | 4 |
15.830 | 17081 | 4 |
15.840 | 13036 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
LU7
The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
NST (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online